Showing 108 of 108on this page. Filters & sort apply to loaded results; URL updates for sharing.108 of 108 on this page
Reprieve Cardiovascular Looks to Transform ADHF Decongestion Management ...
Reprieve Cardiovascular
Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure ...
Reprieve Cardiovascular - 2025 Company Profile, Funding & Competitors ...
REPRIEVE CARDIOVASCULAR - Reprieve Cardiovascular, Inc. Trademark ...
REPRIEVE Trial - Cardiovascular Imaging Research Center
Reprieve Cardiovascular raises $61M for heart failure system
The REPRIEVE trial: Developing a cardiovascular disease prevention ...
How Reprieve Cardiovascular is revolutionizing heart failure care ...
Reprieve Cardiovascular Guided Diuretic Therapy - YouTube
Reprieve Cardiovascular Nabs $42M to Expand Intelligent Fluid ...
A Brief History of Reprieve Cardiovascular – CBM
Reprieve Cardiovascular Debuts at Heart Failure 2018 - Medical Product ...
Clinical Trial | Reprieve Cardiovascular
Reprieve Cardiovascular Raises $61 Million, Launches FASTR II Pivotal ...
MedTech Strategist - Reprieve Cardiovascular Accelerates ADHF Treatment ...
Reprieve Cardiovascular announces funding and trial enrolment ...
Cardiovascular Disease Prevention in Patients With HIV: The REPRIEVE ...
Revisiting Cardiovascular Risks of Abacavir: Insights from the REPRIEVE ...
Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million ...
Reprieve Cardiovascular Builds Clinical Momentum with Positive Results ...
Reprieve Cardiovascular raised $61m for heart failure treatment system
Andrew Halpert - VP of R&D at Reprieve Cardiovascular | The Org
Reprieve Cardiovascular raises $61M; Conformal Medical nets $32M for ...
Reprieve Reprieve Reports TREAT AHF Study | Reprieve Cardiovascular
Funding awarded to heart failure device trial Reprieve Cardiovascular ...
How Does Reprieve Cardiovascular Company Work? – CanvasBusinessModel.com
REPRIEVE Results published: Pitavastatin to Prevent Cardiovascular ...
Reprieve Cardiovascular Emerges From Stealth Mode With $42M Financing ...
Marketing Mix Analysis of Reprieve Cardiovascular – CanvasBusinessModel.com
What is Brief History of Reprieve Cardiovascular Company ...
Reprieve Cardiovascular Secures $61 Million Financing and Enrolls First ...
NAFLD IS COMMON AND ASSOCIATED WITH CARDIOVASCULAR RISK IN REPRIEVE ...
Reprieve Cardiovascular: $42 Million Raised To Build Automated Diuretic ...
Reprieve Logo
Study Demonstrates Potential of Reprieve Cardiovascular's Heart Failure ...
Abiomed gets in on $7m round for RenalGuard affiliate Reprieve ...
Proud to share a major milestone for Reprieve Cardiovascular: we’ve ...
Reprieve System for the Treatment of Patients With Acute Decompensated ...
Clinical Data from Reprieve Cardiovascular's Successful First-in-Human ...
Reprieve Decongestion Management System for Heart Failure Clinical ...
First-in-human results “demonstrate potential of Reprieve system” in ...
Abacavir is associated with elevated risk for cardiovascular events in ...
REPRIEVE Trial Published in New England Journal of Medicine ...
HIV and Heart Disease: A REPRIEVE for Women | NHLBI, NIH
Polygenic Scores and Preclinical Cardiovascular Disease in Individuals ...
Reprieve lands $42m to advance heart failure trials - Medical Device ...
Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT ...
REPRIEVE Trial "Cardiovascular Disease Prevention in People with HIV ...
REPRIEVE Clinical Trial on Preventing HIV-Related Heart Disease Still ...
THT 2025: Reprieve system meets endpoints in FASTR randomised pilot study
New Results Report Advancements in Reprieve-Guided Diuretic Therapy for ...
Slides of Study Results – ACTG
PPT - Gregg W. Stone, MD Columbia University Medical Center The ...
Case study: Using real-world data to advance heart failure research
Case study: Driving innovation for heart failure | Truveta
BHIVA rapid guidance on the use of statins for primary prevention of ...
Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major ...